| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,111 |
3,552 |
$116K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,918 |
1,607 |
$78K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,240 |
1,021 |
$53K |
| 87428 |
|
848 |
775 |
$35K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
432 |
333 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,107 |
968 |
$20K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
282 |
265 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,164 |
1,048 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
290 |
238 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
276 |
263 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
121 |
94 |
$1K |
| 87807 |
|
26 |
20 |
$92.48 |
| 81002 |
|
13 |
12 |
$5.22 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
143 |
134 |
$0.23 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
102 |
54 |
$0.00 |
| 4004F |
|
33 |
18 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
49 |
25 |
$0.00 |
| 1036F |
|
37 |
19 |
$0.00 |